Curaleaf launched a hostile takeover bid for Aurora Cannabis at $4 per share (45% premium), comprising 0.34 Curaleaf shares plus $0.75 cash, with a $5 per share cap. Aurora's board will consider the offer but criticized the financing details and price cap. The combination appeals due to Aurora's strong medical marijuana business with higher margins, though hostile bids have historically struggled.
Axe note: Curaleaf’s bid offers premium but faces skepticism, with implications largely outside South Africa.